Story perspectives

NPPA Caps Margins on 137 Cancer Drugs at 30%

By Drooid · Oct 20, 2026, 4:17 AM UTC · How we work

Summary

Story summary

India’s National Pharmaceutical Pricing Authority caps trade margins on 137 cancer drugs at 30% of MRP.
The cap takes effect on 9 November 2026, requiring manufacturers to file revised MRPs within seven days of the Oct 17 gazette.
NPPA estimates MRPs could fall 20-70%, saving roughly INR2,500 crore annually.
State drug controllers will enforce the cap and audit hospitals.
Experts caution hospitals might increase consumable fees to compensate for reduced drug margins.

1 of 1

Story summary

India’s National Pharmaceutical Pricing Authority caps trade margins on 137 cancer drugs at 30% of MRP.
The cap takes effect on 9 November 2026, requiring manufacturers to file revised MRPs within seven days of the Oct 17 gazette.
NPPA estimates MRPs could fall 20-70%, saving roughly INR2,500 crore annually.
State drug controllers will enforce the cap and audit hospitals.
Experts caution hospitals might increase consumable fees to compensate for reduced drug margins.